Health Dictionary Find a Doctor

Osteogenesis imperfecta

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Osteogenesis imperfecta is a genetic bone disorder. People with OI are born without the proper protein (collagen), or the ability to make it, usually because of a deficiency of Type-I collagen.[1] People with OI either have less collagen than normal or the quality is poorer than normal. As collagen is an important protein in bone structure, this impairment causes those with the condition to have weak or fragile bones.[2]

References

  1. Rauch F, Glorieux FH (2004). “Osteogenesis imperfecta”. Lancet. 363 (9418): 1377–85. PMID 15110498.
  2. “Osteogenesis Imperfecta Foundation: Fast Facts”. Retrieved 2007-07-05.


Template:WikiDoc Sources

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historical Perspective

The condition, or types of it, have had various other names over the years and in different nations. Among some of the most common alternatives are Ekman-Lobstein syndrome, Vrolik syndrome, and the colloquial glass-bone disease. The name “Osteogenesis Imperfecta” dates to at least 1895[1] and has been the usual medical term in the twentieth century to present. The current four type system began with Sillence in 1979.[2] An older system deemed less severe types “Osteogenesis Imperfecta Tarda” while more severe forms were deemed “Osteogenesis Imperfecta Congenita.”[3] As this did not differentiate well, and all forms are congenital, this has since fallen out of favour.

The condition has been found in an Ancient Egyptian mummy from 1000 BC. The Norse king Ivar the Boneless may have had this condition as well. The earliest studies of it began in 1788 with the Swede Olof Jakob Ekman. He described the condition in his doctoral thesis and mentioned cases of it going back to 1678. In 1831, Edmund Axmann described it in himself and two brothers. Johann Friedrich Georg Christian Martin Lobstein dealt with it in adults in 1833. Willem Vrolik did work on the condition in the 1850s. The idea that the adult and newborn forms were the same came in 1897 with Martin Benno Schmidt.[4]

References

  1. K. Buday, Beiträge zur Lehre von der Osteogenesis imperfecta (1895)
  2. Sillence DO, Senn A, Danks DM (1979). “Genetic heterogeneity in osteogenesis imperfecta”. J. Med. Genet. 16 (2): 101–16. PMID 458828.
  3. “Osteogenesis Imperfecta Foundation: Glossary”. Retrieved 2007-07-05.
  4. Template:WhoNamedIt


Template:WikiDoc Sources

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Classification

There are eight types of OI, Type I being the most common, though the symptoms range from person to person.

Type Description OMIM
Type I mild 166240 (IA), 166200 (IB)
Type II severe and usually lethal in the perinatal period 166210
Type III considered progressive and deforming 259420
Type IV deforming, but with normal scleras 166220
Type V shares the same clinical features of IV, but has unique histologic findings (“mesh-like”) 610967
Type VI shares the same clinical features of IV, but has unique histologic findings (“fish scale”) 610968
Type VII associated with cartilage associated protein 610682
Type VIII associated with leprecan 610915

Type I

Collagen is of normal quality but is produced in insufficient quantities:

  • Bones fracture easily
  • Slight spinal curvature
  • Loose joints
  • Poor muscle tone
  • Discolouration of the sclera (whites of the eyes), usually giving them a blue-gray color. The blue-gray color of the sclera is due to the reflection of underlying choroidal veins. The underlying choroidal veins reflect through the sclera because there is defective synthesis of type 1 collagen.
  • Early loss of hearing in some children
  • Slight protrusion of the eyes

IA and IB are defined to be distinguished by the absence/presence of dentinogenesis imperfecta (characterized by opalescent teeth.) (Absent in IA, present in IB.)

Type II

Collagen is not of a sufficient quality or quantity

Type II can be further subclassified into groups A, B, C, which are distinguished by radiographic evaluation of the long bones and ribs. Type IIA demonstrates broad and short long bones with broad and beaded ribs. Type IIB demonstrates broad and short long bones with thin ribs that have little or no beading. Type IIC demonstrates thin and longer long bones with thin and beaded ribs.

Type III

Collagen quantity is sufficient but is not of a high enough quality

  • Bones fracture easily, sometimes even before birth
  • Bone deformity, often severe
  • Respiratory problems possible
  • Short stature, spinal curvature and sometimes barrel-shaped rib cage
  • Loose joints
  • Poor muscle tone in arms and legs
  • Discolouration of the sclera (whites of the eyes)
  • Early loss of hearing, sometimes

Type III is distinguished among the other classifications as being the “Progressive Deforming” type, wherein a neonate presents with mild symptoms at birth and develops the aforementioned symptoms throughout life. Lifespan may be normal, albeit with severe physical handicapping.

Type IV

Collagen quantity is sufficient but is not of a high enough quality

  • Bones fracture easily, especially before puberty
  • Short stature, spinal curvature and barrel-shaped rib cage
  • Bone deformity is mild to moderate
  • Early loss of hearing

Similar to Type I, Type IV can be further subclassified into types IVA and IVB characterized by absence (IVA) or presence (IVB) of dentinogenesis imperfecta.

Type V

OI Type V in Adult
OI Type V in Child

Same clinical features as Type IV. Distinguished histologically by “mesh-like” bone appearance. Further characterized by the “V Triad” consisting of a) radio-opaque band adjacent to growth plates, b) hypertrophic calluses at fracture sites, and c) calcification of the radioulnarinterosseous membrane.

  • As per Doctors Francis Glorieux, Frank Rauch, and Leanne Ward in the Shriners Hospital for Children in Quebec[1]

OI Type V leads to calcification of the membrane between the two forearm bones, making it difficult to turn the wrist. Another symptom is abnormally large amounts of repair tissue (hyperplasic callus) at the site of fractures. At the present time, the cause for Type V is unknown, though doctors have determined that it is inherited.

X-Ray OI Type V in Adult X-Ray OI Type V Kid

More on Type V Research More on OI Study

Type VI

Same clinical features as Type IV. Distinguished histologically by “fish-scale” bone appearance.

Type VII

  • In 2005 a recessive form called “Type VII” was discovered. Thus far it seems to be limited to a First Nations people in Quebec.

References

  1. Glorieux FH, Rauch F, Plotkin H; et al. (2000). “Type V osteogenesis imperfecta: a new form of brittle bone disease”. J. Bone Miner. Res. 15 (9): 1650–8. PMID 10976985.


Template:WikiDoc Sources

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pathophysiology

As a genetic disorder, OI is an autosomal dominant defect. Most people with OI receive it from a parent but it can also be an individual (de novo or “sporadic”) mutation.

References


Template:WikiDoc Sources

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Causes

References


Template:WikiDoc Sources

Differentiating Osteogenesis imperfecta from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Osteogenesis imperfecta must be differentiated from other diseases that cause lowering bone mineral density (BMD), such as osteoporosis, scurvy, osteomalacia, multiple myeloma, and homocysteinuria.

Differentiating Osteogenesis Imperfecta from other Diseases

Differential Diagnosis Similar Features Differentiating Features
Osteogenesis imperfecta
Osteoporosis
  • On physical examination, demonstrates acute musculoskletal pain, if fracture happened
  • On imaging studies, demonstrates severe decrease in BMD
Idiopathic transient osteoporosis of hip
  • On physical examination, demonstrates acute hip pain
  • On imaging studies, demonstrates sub-chondoral cortical loss and diffuse osteopenia of the femoral neck
  • On history, demonstrates mostly involvement of pregnant women and young men
  • On history, demonstrates to be self-limiting in 6-8 months
Osteomalacia
Scurvy
Multiple myeloma
  • On physical examination, demonstrates diffuse bone pain and tenderness
  • On imaging studies, demonstrates osteolytic lesions in the bones
Homocystinuria

References


Template:WikiDoc Sources

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Epidemiology and Demographics

Frequency is approximately the same across groups, but for unknown reasons the Shona and Ndebele of Zimbabwe seem to have a higher proportion of Type III to Type I than other groups.[1]. However, a similar pattern was found in segments of the Nigerian and South African population. In these varied cases the total number of OIs of all four types was roughly the same as any other ethnicity.

References

  1. Viljoen D, Beighton P (1987). “Osteogenesis imperfecta type III: an ancient mutation in Africa?”. Am. J. Med. Genet. 27 (4): 907–12. doi:10.1002/ajmg.1320270417. PMID 3425600.


Template:WikiDoc Sources

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Natural History, Complications and Prognosis

References


Template:WikiDoc Sources

Diagnosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | X-ray | CT | Other Imaging Findings

Treatment

Treatment

Medical Therapy | Surgery

Case Studies

Case Studies

Case#1


Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH